ASCO's chief medical officer Dr. Richard L. Schilsky and I discuss the refinement of cancer surgery, the critical importance of federally funded research, and ASCO's research priorities for the oncology...
"Quality improvement happens slowly if you're in a silo": Dr. Jeffery Ward and I discuss the important updates to ASCO's alternative payment model for high-quality oncology care.
As we begin our work in 2020, I am excited that we are building on the remarkable successes of 2019, and the years before, with growing collaboration and sharpening focus.
ASCO's delegation to the AMA HOD invites all ASCO members to share their thoughts and concerns concerning issues affecting the practice of oncology, as your input directly impacts the delegation's work.
As physicians, we have a responsibility to our patients in the clinic and in the ballot box. Ms. Talya Laufer and I advocate for a politically engaged and informed medical workforce.
Key cancer-related topics discussed at the AMA-HOD meeting included alcohol ingestion as a causation risk factor, appropriate guidelines for opioids in the cancer setting, and the use of de-identified patient...
